J vs TRDA · P/E 36, $14.40B cap vs P/E 12, rev $210.8M
Jacobs Solutions Inc. (J) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
J does not have a complete income-statement cache yet.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
J currently screens at market cap $14.40B and trailing P/E 36.0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the J and TRDA stock pages for the full models.
Not investment advice.